Aridis Pharmaceuticals Analyst Ratings

Benzinga ·  10/21/2023 01:52

What is the target price for Aridis Pharmaceuticals (ARDS)?The latest price target for Aridis Pharmaceuticals (OTCQB: ARDS) was reported by HC Wainwright & Co. on October 20, 2023. The analyst firm set a price target for $2.00 expecting ARDS to rise to within 12 months (a possible 3821.57% upside). 2 analyst firms have reported ratings in the last year.What is the most recent analyst rating for Aridis Pharmaceuticals (ARDS)?The latest analyst rating for Aridis Pharmaceuticals (OTCQB: ARDS) was provided by HC Wainwright & Co., and Aridis Pharmaceuticals maintained their buy rating.When is the next analyst rating going to be posted or updated

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment